1
|
Giovanni RE, Francesca B, Anna N, Cristina N, Marco P, Linda N, Pasquale GC, Fabio F, Rosaria F, Franco C, Mariella DS, Tommaso C, Chiara M, Irene S, Sonia B, Luigi DS, Filippo B, Francesca M, Cristina P, Alessandra S, Enrico T, Gianni A. Integrating conventional and complementary treatments in cancer care: The process within the public healthcare system of the region of Tuscany, Italy. Complement Ther Clin Pract 2023; 51:101738. [PMID: 36812736 DOI: 10.1016/j.ctcp.2023.101738] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2022] [Revised: 02/06/2023] [Accepted: 02/13/2023] [Indexed: 02/22/2023]
Affiliation(s)
- Rossi Elio Giovanni
- Clinic for Complementary Medicine and Diet in Oncology, Local Health Unit Tuscany North West, Lucca, Italy.
| | - Bosinelli Francesca
- Clinic for Complementary Medicine and Diet in Oncology, Local Health Unit Tuscany North West, Lucca, Italy
| | - Navari Anna
- Clinic for Complementary Medicine and Diet in Oncology, Local Health Unit Tuscany North West, Lucca, Italy
| | - Noberasco Cristina
- Clinic for Complementary Medicine and Diet in Oncology, Local Health Unit Tuscany North West, Lucca, Italy
| | - Picchi Marco
- Clinic for Complementary Medicine and Diet in Oncology, Local Health Unit Tuscany North West, Lucca, Italy
| | - Nurra Linda
- Clinic for Complementary Medicine and Diet in Oncology, Local Health Unit Tuscany North West, Lucca, Italy
| | - Guido Carmelo Pasquale
- Center for Acupuncture and Traditional Chinese Medicine, Local Health Unit Central Tuscany, Firenze, Italy
| | - Firenzuoli Fabio
- Integrative Medicine Center, CERFIT, University Hospital of Careggi Hospital, Firenze, Italy
| | - Ferreri Rosaria
- Center for Integrative Medicine, Hospital of Pitigliano, Local Health Unit South East Tuscany, Grosseto, Italy
| | - Cracolici Franco
- Center for Integrative Medicine, Hospital of Pitigliano, Local Health Unit South East Tuscany, Grosseto, Italy
| | | | - Conti Tommaso
- Tuscan Regional Center for Integrative Medicine, Firenze, Italy
| | | | - Sacco Irene
- Tuscan Regional Center for Integrative Medicine, Firenze, Italy
| | - Baccetti Sonia
- Tuscan Regional Center for Integrative Medicine, Firenze, Italy
| | | | - Bosco Filippo
- Breast Unit, AOUP, University Hospital of Pisa, Italy
| | | | - Pennucci Cristina
- Oncology Department, Local Health Unit Tuscany North West, Carrara, Italy
| | | | - Tucci Enrico
- Oncology Department, Local Health Unit South East Tuscany, Arezzo, Italy
| | - Amunni Gianni
- Coordinator for the Tuscan Oncology Network, University Hospital of Careggi, Firenze, Italy
| |
Collapse
|
2
|
Finding the value in oncology massage: A mixed-method study of cancer services and survivors in Australia. ADVANCES IN INTEGRATIVE MEDICINE 2020. [DOI: 10.1016/j.aimed.2020.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
3
|
Grant SJ, Hunter J, Seely D, Balneaves LG, Rossi E, Bao T. Integrative Oncology: International Perspectives. Integr Cancer Ther 2019; 18:1534735418823266. [PMID: 30791736 PMCID: PMC7240876 DOI: 10.1177/1534735418823266] [Citation(s) in RCA: 32] [Impact Index Per Article: 6.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/16/2022] Open
Abstract
Interest in integrative oncology (IO) is growing globally. Patients with cancer are actively using traditional complementary and integrative medicine (TCIM) as part of their cancer and survivorship care. Published studies from around the world report increasing use of TCIM by people living with cancer. This article summarizes the presentations that took place during a symposium titled, "Integrative Oncology: International Perspectives" at the International Research Congress on Integrative Medicine and Health in Baltimore, 2018. The purpose of the presentations was to examine whether cancer services across a variety of geographical regions, including Australia, Canada, the United States, and the European Union, were actively responding to cancer survivors' demand for TCIM. The presenters highlighted utilization rates and both facilitators and barriers to the provision of IO services in their respective countries and regions. The audience discussion following the presentations drew out many noteworthy perspectives.
Collapse
Affiliation(s)
- Suzanne J Grant
- 1 Western Sydney University, Penrith, NSW, Australia.,2 Chris O'Brien Lifehouse Comprehensive Cancer Centre, Camperdown, NSW, Australia
| | - Jennifer Hunter
- 1 Western Sydney University, Penrith, NSW, Australia.,3 The University of Sydney, Australia
| | - Dugald Seely
- 4 Ottawa Integrative Cancer Centre, Ottawa, ON, Canada.,5 Canadian College of Naturopathic Medicine, Toronto, ON, Canada
| | | | - Elio Rossi
- 7 Coordinating Center of Complementary Medicine-Local Health Unit Tuscany North West, Lucca, Italy
| | - Ting Bao
- 8 Memorial Sloan Kettering Cancer Center, NY, USA
| |
Collapse
|
4
|
What can a third sector organisation provide for people with breast cancer that public health services cannot? Developing support services in response to service evaluation. Eur J Integr Med 2019. [DOI: 10.1016/j.eujim.2019.100943] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
|
5
|
Smith CA, Hunter J, Delaney GP, Ussher JM, Templeman K, Grant S, Oyston E. Integrative oncology and complementary medicine cancer services in Australia: findings from a national cross-sectional survey. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 2018; 18:289. [PMID: 30373631 PMCID: PMC6206936 DOI: 10.1186/s12906-018-2357-8] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 06/19/2018] [Accepted: 10/19/2018] [Indexed: 01/01/2023]
Abstract
Background Individuals living with and beyond a cancer diagnosis are increasingly using complementary therapies and medicines (CM) to enhance the effectiveness of cancer treatment, manage treatment-related side effects, improve quality-of-life, and promote self-efficacy. In response to the increasing use and demand for CM by cancer patients, interest in the implementation of Integrative Oncology (IO) services that provide CM alongside conventional cancer care in Australia and abroad has developed. The extent that cancer services in Australia are integrating CM is uncertain. Thus, the aim of this study was to identify IO services in Australia and explore barriers and facilitators to IO service provision. Methods A national, cross-sectional survey of healthcare organisations was conducted in 2016. Organisations in the public and private sectors, including not-for-profit organisations that provided cancer care in hospital or community setting, were included. Results A response rate of 93.2% was achieved (n = 275/295). Seventy-one organisations (25.8%) across all states/territories, except the Northern Territory, offered IO albeit in a limited amount by many. Most common IO services included massage, psychological-wellbeing, and movement modalities in hospital outpatient or inpatient settings. There were only a few instances where biological-based complementary medicine (CM) therapies were prescribed. Funding was often mixed, including patient contributions, philanthropy, funding by the organisation, and volunteer practitioners. Of the 204 non-IO providers, 80.9% had never provided any IO service. Overwhelmingly, the most common barrier to IO was a lack of funding, followed by uncertainty about patient demand, choice of services, and establishing such services. Less-common barriers were a lack of evidence, and support from oncologists or management. More funding, education and training, and building the evidence-base for CM were the most commonly suggested solutions. Conclusion IO is increasingly being provided in Australia, although service provision remains limited or non-existent in many areas. Mismatches appear to exist between low IO service provision, CM evidence, and high CM use by cancer patients. Greater strategic planning and policy guidance is indicated to ensure the appropriate provision of, and equitable access to IO services for all Australian cancer survivors. Electronic supplementary material The online version of this article (10.1186/s12906-018-2357-8) contains supplementary material, which is available to authorized users.
Collapse
|
6
|
Kuo YT, Chang TT, Muo CH, Wu MY, Sun MF, Yeh CC, Yen HR. Use of Complementary Traditional Chinese Medicines by Adult Cancer Patients in Taiwan: A Nationwide Population-Based Study. Integr Cancer Ther 2018; 17:531-541. [PMID: 28665160 PMCID: PMC6041896 DOI: 10.1177/1534735417716302] [Citation(s) in RCA: 52] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2016] [Revised: 03/29/2017] [Accepted: 04/14/2017] [Indexed: 12/23/2022] Open
Abstract
BACKGROUND Many patients with cancer seek complementary and alternative medicine treatments. We investigated the use of traditional Chinese medicine (TCM) by adult cancer patients in Taiwan. METHODS We reviewed the Registry for Catastrophic Illness Patients Database of Taiwan, and included all adult patients diagnosed cancer, based on the International Classification of Diseases (ninth revision), from 2001 to 2009 and followed until 2011. This database allowed categorization of patients as TCM users (n = 74 620) or non-TCM users (n = 508 179). All demographic and clinical claims data were analyzed. RESULTS Compared with non-TCM users, TCM users were younger and more likely to be female, white-collar workers, and reside in highly urbanized areas. The average interval between cancer diagnosis and TCM consultation was 15.3 months. The most common cancer type was breast cancer in TCM users (19.4%), and intrahepatic bile duct cancer in non-TCM users (13.6%). The major condition for which TCM users visited clinics were endocrine, nutritional and metabolic diseases, and immunity disorders (23.2%). A total of 33.1% of TCM users visited TCM clinics more than 9 times per year and their time from diagnosis to first TCM consultation was 5.14 months. The most common TCM treatment was Chinese herbal medicine. The common diseases for which cancer patients sought TCM treatment were insomnia, malaise and fatigue, dizziness and headache, gastrointestinal disorders, myalgia and fasciitis, anxiety, and depression. Overall, TCM users had a lower adjusted hazard ratio (aHR) for mortality (aHR = 0.69, 95% CI = 0.68-0.70) after adjustment for age, sex, urbanization of residence, occupation, annual medical center visits, and annual non-medical center visits. CONCLUSIONS This study provides an overview of TCM usage among adult cancer patients in Taiwan. TCM use varied among patients with different types of cancer. Physicians caring for cancer patients should pay more attention to their patients' use of complementary TCM.
Collapse
Affiliation(s)
- Yi-Ting Kuo
- Graduate Institue of Chinese Medicine, School of Chinese Medicine, China Medical University, Taichung, Taiwan
- Department of Chinese Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi, Taiwan
| | - Tung-Ti Chang
- Graduate Institue of Chinese Medicine, School of Chinese Medicine, China Medical University, Taichung, Taiwan
- Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan
| | - Chih-Hsin Muo
- Health Data Management Office, China Medical University Hospital, Taichung, Taiwan
| | - Mei-Yao Wu
- Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan
| | - Mao-Feng Sun
- Graduate Institue of Chinese Medicine, School of Chinese Medicine, China Medical University, Taichung, Taiwan
- Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan
| | - Chia-Chou Yeh
- Department of Chinese Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-Yi, Taiwan
- School of Post-Baccalaureate Chinese Medicine, Tzu Chi University, Hualien, Taiwan
| | - Hung-Rong Yen
- Graduate Institue of Chinese Medicine, School of Chinese Medicine, China Medical University, Taichung, Taiwan
- Department of Chinese Medicine, China Medical University Hospital, Taichung, Taiwan
- Department of Biotechnology, Asia Univeristy, Taichung, Taiwan
| |
Collapse
|
7
|
Hunter J, Ussher J, Parton C, Kellett A, Smith C, Delaney G, Oyston E. Australian integrative oncology services: a mixed-method study exploring the views of cancer survivors. BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE 2018; 18:153. [PMID: 29743054 PMCID: PMC5944107 DOI: 10.1186/s12906-018-2209-6] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Received: 09/29/2017] [Accepted: 04/17/2018] [Indexed: 12/22/2022]
Abstract
Background The significant use of traditional and complementary medicine (T&CM) by cancer survivors is well documented. The aim of this study was to explore cancer survivors’ views on integrating T&CM services with conventional cancer care. Method A mixed-method study design with an emphasis on qualitative methodology was used to conduct and analyse four focus group interviews and an on-line survey. Purposive sampling recruited 33 cancer survivors and caregivers from Arabic, Vietnamese, Chinese and Anglo-European Australian backgrounds who participated in one of four focus group interviews, and 121 cancer survivors who responded to an on-line survey. The inductive thematic analysis was augmented with a descriptive statistical analysis. Results Most participants had used T&CM therapies or consulted T&CM practitioners as an adjuvant during and/or after their initial cancer treatment. Two themes emerged: ‘positive perceptions and experiences’ and ‘barriers and unmet needs’. Participants emphasised that T&CM was not a ‘luxury item’, rather it was considered important for managing side effects and comorbidities, rehabilitation and quality of life. A wide range of complex, interrelated barriers and solutions to IO service provision and access were identified. Structural barriers included inadequate service provision, medical practitioner attitudes, logistical constraints and funding. Personal barriers were influenced by the severity of impairment and disability; attitudes, beliefs and knowledge about T&CM; and available resources (e.g. finances, time, transport). Unmet need and inequitable access was exacerbated by geographical location, ethnicity and ability to pay. There was a mismatch between where participants were accessing T&CM services and their preference for IO service delivery. Participants perceived hospital-based IO services availability to have several benefits, including the T&CM practitioners having more expert knowledge about cancer care, the convenience of co-locating oncology services, and potentially lower out-of-pocket costs. Conclusion Patients’ use, preferences and needs for T&CM services in the oncology setting are important for informing service provision. Inequitable, unmet need reflected the increasing demand and expectation from patients for their oncology teams to be well informed about the benefits, risks and indications for T&CM use, and for the public and private health sectors to formally integrate and fund IO services. Electronic supplementary material The online version of this article (10.1186/s12906-018-2209-6) contains supplementary material, which is available to authorized users.
Collapse
|
8
|
Keyhanmehr AS, Kolouri S, Heydarirad G, Mofid B, Mosavat SH. Aromatherapy for the management of cancer complications: A narrative review. Complement Ther Clin Pract 2018; 31:175-180. [PMID: 29705452 DOI: 10.1016/j.ctcp.2018.02.009] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/18/2017] [Revised: 02/04/2018] [Accepted: 02/09/2018] [Indexed: 02/08/2023]
Affiliation(s)
- Armaghan Sadat Keyhanmehr
- Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Sepideh Kolouri
- Department of Traditional Persian Medicine, School of Medicine, Semnan University of Medical Sciences, Semnan, Iran
| | - Ghazaleh Heydarirad
- Department of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
| | - Bahram Mofid
- Department of Clinical Oncology, Shohada-e-Tajrish Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
| | - Seyed Hamdollah Mosavat
- Research Centre for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
| |
Collapse
|
9
|
Charlesworth E, Hughes J, Plant H, Carballo L. Complementary therapy for people with cancer; the patient’s perspective. Eur J Integr Med 2018. [DOI: 10.1016/j.eujim.2017.10.009] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
10
|
Kirshbaum MN, Stead M, Bartys S. An exploratory study of reiki experiences in women who have cancer. Int J Palliat Nurs 2016; 22:166-72. [DOI: 10.12968/ijpn.2016.22.4.166] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - Serena Bartys
- Centre for Applied Psychological and Health Research, Institute for Research in Citizenship and Applied Human Sciences, University of Huddersfield
| |
Collapse
|
11
|
Bar-Sela G, Danos S, Visel B, Mashiach T, Mitnik I. The effect of complementary and alternative medicine on quality of life, depression, anxiety, and fatigue levels among cancer patients during active oncology treatment: phase II study. Support Care Cancer 2014; 23:1979-85. [PMID: 25516212 DOI: 10.1007/s00520-014-2560-1] [Citation(s) in RCA: 27] [Impact Index Per Article: 2.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/11/2014] [Accepted: 12/07/2014] [Indexed: 11/25/2022]
Abstract
BACKGROUND During the past decade, there has been growing interest in complementary and alternative medicine (CAM) among cancer patients and it is being integrated more frequently within conventional cancer centers. The long-term effect of mind-body therapies on quality of life (QoL), depression, anxiety, and fatigue was tested prospectively in this study. PATIENTS AND METHODS Cancer patients who received six weekly sessions of CAM during their oncological treatments participated in the study. The Hospital Anxiety and Depression Scale (HADS), Brief Fatigue Inventory (BFI) and QoL-EORTC-C30 were completed during the intervention and follow-up period. RESULTS Over a two-year period, 163 patients entered the study, 135 of whom completed all six CAM sessions. An improvement was demonstrated in the median of BFI from 4.8 to 3.9 (p < 0.001), HADS-Anxiety from 8 to 7 (p < 0.001) and HADS-Depression from 7 to 6 (p < 0.001) after 12 weeks. In addition, the median of global QoL improved from 50 to 67 (p < 0.001), and a significant improvement was noticed in several parameters on the functioning and symptoms scales of the QoL-EORTC-C30. CONCLUSION Cancer patients who completed six weekly sessions of CAM improved significantly on measured outcomes, regardless of their demographic characteristics.
Collapse
Affiliation(s)
- Gil Bar-Sela
- Division of Oncology, Rambam Health Care Campus, POB 9602, Haifa, 31096, Israel,
| | | | | | | | | |
Collapse
|
12
|
Rossi E, Vita A, Baccetti S, Di Stefano M, Voller F, Zanobini A. Complementary and alternative medicine for cancer patients: results of the EPAAC survey on integrative oncology centres in Europe. Support Care Cancer 2014; 23:1795-806. [DOI: 10.1007/s00520-014-2517-4] [Citation(s) in RCA: 54] [Impact Index Per Article: 5.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/26/2014] [Accepted: 11/10/2014] [Indexed: 10/24/2022]
|
13
|
Dyer J, Thomas K, Sandsund C, Shaw C. Is reflexology as effective as aromatherapy massage for symptom relief in an adult outpatient oncology population? Complement Ther Clin Pract 2013; 19:139-46. [PMID: 23890460 DOI: 10.1016/j.ctcp.2013.03.002] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/05/2013] [Revised: 03/12/2013] [Accepted: 03/18/2013] [Indexed: 10/26/2022]
Abstract
AIM To test whether reflexology was inferior to aromatherapy massage for ameliorating self-selected problems or concerns. DESIGN Non-blinded, randomised study with a 1:1 allocation. Adult outpatients recruited from a UK cancer centre, randomised by the minimisation method to either four aromatherapy massage or four reflexology sessions. OUTCOME MEASURES MYCaW scores at baseline and completion; VAS (relaxation) pre and post-sessions. ANALYSIS Unpaired t-test for the primary outcome; analysis of variance tests for repeated measures for VAS (relaxation); descriptive statistics (means and 95% confidence intervals) and content analysis for patient comments. RESULTS 115 subjects (58 aromatherapy massage, 57 reflexology) recruited. Reflexology was found to be no less effective than aromatherapy massage for MYCaW first concerns (p = 0.046). There was no statistical difference between groups for MYCaW second concerns or overall well-being scores, proportions of patients gaining clinical benefit, VAS scores over time (p = 0.489) or between groups (p = 0.408) or in the written responses.
Collapse
Affiliation(s)
- Jeannie Dyer
- Therapies Department, The Royal Marsden NHS Foundation Trust, London SW3 6JJ, UK.
| | | | | | | |
Collapse
|